It’s been another challenging year. At the end of 2020, we were all hopeful that 2021 would bring with it a chance to get back to normal, but that has so far eluded most of the world. However, the year did bring with it a lot to be grateful for—the various COVID-19 vaccines, made possible by science and arguably made viable by intellectual property rights—were initially rolled out in the United States beginning in late 2020 and became available to the masses in the spring of 2021. Today, about 60% of the U.S. population is fully vaccinated, and there would be many hundreds of thousands more deaths without the vaccines. IPWatchdog was able to have its first annual LIVE! event as a result of the vaccines as well, and it was a huge success. I’m very thankful to be part of such a great team and to have such truly genuine and wonderful bosses in Gene and Renée. Below are responses to our request for comments on what the IP community is thankful for this year. If you’d like to be added to our mailing list for these roundup perspective pieces, please write us at [email protected].
Recent Posts
- Other Barks and Bites for Friday, January 17: Teva Files IRA Challenge Amid Second Round of Medicare Negotiations; Ninth Circuit Says Kinetic Sculptures Can Be Sufficiently ‘Fixed’ for Copyright; USPTO Publishes Inventorship FAQs for AI-Assisted Inventions
- USPTO Fee Report: Discounts Don’t Cut It for Incentivizing New Patent Participants
- Federal Circuit Splits on Whether Toddler Tub May Infringe
- CAFC Rules Patent Applications are Considered Pre-AIA Prior Art By Filing Date, Not Publication Date
- The Biden Administration Rolls the Dice on NIH Patent Licensing